Latest Breaking News On - Denis scheweead - Page 1 : comparemela.com

OSE Immunotherapeutics has presented data on its anti-IL-7 receptor antagonist OSE-127 for the treatment of acute lymphoblastic leukemia.

Sachsen anhaltUniversity medical centerUnited statesNew orleansNicolas poirierDenis scheweeadLennart lenkAmerican society of hematologyUniversity medical center schleswig holsteinChristian albrechts university kielDepartment of pediatricsAmerican society